HOOKIPA Pharma
Stock Forecast, Prediction & Price Target
HOOKIPA Pharma Financial Estimates
HOOKIPA Pharma Revenue Estimates
HOOKIPA Pharma EBITDA Estimates
HOOKIPA Pharma Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $18.44M N/A | $14.24M -22.76% | $20.12M 41.26% | Avg: $9.85M Low: $8.45M High: $11.79M avg. -51.06% | Avg: $5.83M Low: $5.01M High: $6.98M avg. -40.77% | Avg: $67.24M Low: $57.75M High: $80.51M avg. 1052.79% | Avg: $199.79M Low: $171.60M High: $239.23M avg. 197.11% |
Net Income
% change YoY
| $-75.66M N/A | $-65.14M 13.90% | $-81.58M -25.22% | Avg: $-103.75M Low: $-72.78M High: $-46.31M avg. -27.17% | Avg: $-131.40M Low: $-71.84M High: $-60.49M avg. -26.64% | Avg: $-47.57M Low: $-59.78M High: $-38.84M avg. 63.79% | Avg: $13.23M Low: $10.80M High: $16.62M avg. 127.81% |
EBITDA
% change YoY
| $-81.67M N/A | $-73.15M 10.43% | $-77.34M -5.72% | Avg: $-9.85M Low: $-11.79M High: $-8.45M avg. 87.26% | Avg: $-5.83M Low: $-6.98M High: $-5.01M avg. 40.77% | Avg: $-67.24M Low: $-80.51M High: $-57.75M avg. -1052.79% | Avg: $-199.79M Low: $-239.23M High: $-171.60M avg. -197.11% |
EPS
% change YoY
| -$2.3 N/A | -$0.99 56.95% | -$8.63 -771.71% | Avg: -$0.64 Low: -$0.77 High: -$0.49 avg. 92.54% | Avg: -$0.7 Low: -$0.76 High: -$0.64 avg. -8.80% | Avg: -$0.5 Low: -$0.63 High: -$0.41 avg. 28.09% | Avg: $0.14 Low: $0.11 High: $0.18 avg. 127.81% |
Operating Expenses
% change YoY
| $100.12M N/A | $87.40M -12.70% | $117.82M 34.80% | Avg: $10.48M Low: $9.00M High: $12.56M avg. -91.09% | Avg: $6.21M Low: $5.33M High: $7.43M avg. -40.77% | Avg: $71.61M Low: $61.50M High: $85.74M avg. 1052.79% | Avg: $212.77M Low: $182.74M High: $254.77M avg. 197.11% |
FAQ
What is HOOKIPA Pharma stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 34.44% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -72.78M, average is -103.75M and high is -46.31M.
What is HOOKIPA Pharma stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 289.51% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $8.45M, average is $9.85M and high is $11.79M.
What is HOOKIPA Pharma stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 59.91% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.77, average is -$0.64 and high is $-0.49.